Back to today’s briefing

Story perspectives

Community Backs Gilead Amid Controversial HIV Lawsuit

2/8/2025

46 6

Summary

Story summary

On November 25, 2024, community leaders rallied behind Gilead in a controversial lawsuit, despite the company's troubling history with HIV medications. While Gilead profited from Truvada, known for its harsh side effects, they neglected to promote the safer option, Descovy. This situation ignites urgent discussions about the pharmaceutical industry's impact on patient care and the necessity for greater patient advocacy in treatment choices.

1 of 1

Story summary

On November 25, 2024, community leaders rallied behind Gilead in a controversial lawsuit, despite the company's troubling history with HIV medications. While Gilead profited from Truvada, known for its harsh side effects, they neglected to promote the safer option, Descovy. This situation ignites urgent discussions about the pharmaceutical industry's impact on patient care and the necessity for greater patient advocacy in treatment choices.